Press Room

2016 AIChE Annual Meeting

Start
Sunday, November 13, 2016 - 00:00
End
Friday, November 18, 2016 - 00:00
Location: San Francisco, United States
Cocrystals amorphous solid dispersions | Hovione

HOVIONE PRESENTATIONS

1. Multi-Scale Modeling in Pharmaceutical Drug Substance Manufacturing
José L.C. Santos, Rui C. Silva and Filipe A.P. Ataíde
Date: Monday, Nov 14
Presentation Time: 12:30 PM
Location: Continental 5 (Hilton San Francisco Union Square)

2. Evaporation of Binary Mixtures and Shell Formation in Spray Dried Droplets
Pedro Valente, Íris Duarte, Tiago Porfirio, Xu Liu, Feng Zhang and Márcio Temtem (in collaboration with University of Texas)
Session: Tools for Accelerating Pharma Development and Innovations in Biopharmaceutical Discovery, Development, and Manufacturing 
Date: Tuesday, Nov 15
Presentation Time: 1:58 PM - 2:20 PM 
Location: Continental 5 (Hilton San Francisco Union Square)

3. Evaluating Mixing Performance in a Stirred Tank Reactor with Different Impeller Geometries and Reactor Size By CFD
Rui C. Silva
, Filipe A.P. Ataíde and José L.C. Santos
Date: Wednesday, Nov 16
Presentation Time: 8:30 AM
Location: Union Square 1 & 2 (Hilton San Francisco Union Square)

4. Scale-up of Reaction and Crystallization Steps of a Commercial Manufacturing Process in a Multi-Purpose Plant Using Mechanistic Modeling 
Filipe A.P. Ataíde, Rui C. Silva and José L.C. Santos
Date: Thursday, Nov 17
Presentation Time: 10:15 AM
Location: Continental 4 (Hilton San Francisco Union Square)

5. Secondary Drying Scale-up Methodology: Eliminating a bottleneck with a Lean Development Approach
Tiago Porfirio, Pedro Valente, Ines Matos, Jorge Moreira, João Vicente, Márcio Temtem and Viriato Semião
Session: Quality By Design in Drug Product Formulation, Design, & Process Development I 
Date: Thursday, Nov 17
Presentation Time: 1:08 PM - 1:27 PM 
Location: Continental 4 (Hilton San Francisco Union Square)

 

HOVIONE POSTERS at POSTER SESSION

Date: Monday, November 14, 2016
Session Time: 3:15 PM - 5:45 PM
Location: Grand Ballroom B (Hilton San Francisco Union Square)

 

1. Modelling Approaches to Spray Drying Process Development, Scale-up and Troubleshooting
Pedro Valente, Íris Duarte, Filipe  Neves and Márcio Temtem

2. Predicting the In Vivo Performance of Amorphous Solid Dispersions Based on Molecular Descriptors and Statistical Analysis
Íris Duarte, João Henriques, João F. Pinto, Márcio Temtem

 

Contact us if you would like to schedule a meeting or to find more about the Hovione presentations at 2016 AIChE Annual Meeting.

Schedule a meeting button | Hovione

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025